ALEXA MARTIN: Open Payments
NPI 1598145732 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,461 in 70 payments from 24 companies in 2025. Trend: 2023 $1,306 · 2024 $1,395 · 2025 $1,461
Food & beverage: $1,461
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $222 |
| Regeneron Healthcare Solutions, Inc. | 7 | $160 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| JAZZ PHARMACEUTICALS INC. | 4 | $86 |
| United Therapeutics Corporation | 3 | $84 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| Genentech USA, Inc. | 4 | $74 |
| GENZYME CORPORATION | 2 | $73 |
| Viatris Specialty LLC | 4 | $67 |
| Axsome Therapeutics, Inc. | 3 | $63 |
Products named: DUPIXENT, NUCALA, XYWAV, Xolair, BREZTRI, YUPELRI, Sunosi, FASENRA.
Industry payments across MO — which companies pay providers there.
